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The Amazon basin is an area of mega-biodiversity1. Different models have been 
proposed1-8 for the establishment of an effective conservation policy, increasing 
sustainability and adding value for biodiversity.  Over  the years,  the Amazon 
region has been caught in a vicious circle that involves deforestation and falling 
employment. There is a hypothesis that links a reduction in deforestation and an 
increase  in  governance  with  the  higher  employment  and  income  that  are 
associated with the development of various processes and products, and this 
has been extolled as a virtuous development circle7. Generating carbon credits 
has also been suggested as a viable development strategy for the region8,9. 
However,  the  real  value  of  biodiversity  directed  to  the  potential  product 
development remains unknown and the estimates are speculative. Evidence-
based  studies  of  the  Amazon  region  should  be  urgently  intensified  and 
expanded. These should be based on the evaluation and potential development 
of  sustainable  high-value  added  products.  Currently,  a  broad  spectrum  of 
technologies from genomics to synthetic biology is available, and these permit 
the collection,  manipulation and effective  evaluation of  countless organisms, 
metabolic pathways and molecules that exist as potential products of a large, 
biodiverse  ecosystem.  Recently,  a  general  development  cycle  has  been 
proposed  for  products  a  given  product  arising  from  the  recombinant  DNA 
technology associated with agri-business10-11. Basically, the development cycle 
establishes  the  appropriate  nomenclature  and  lists  the  interactive  stages 
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involved,  from  the  prospecting  of  candidate  molecules  through  their 
characterisation, testing and deregulation. However, the potential utilisation of 
synthetic biology and recombinant DNA technology directed to the aggregation 
of  biodiversity  value  is  illustrated  here  (Fig.  1).  This  figure  shows possible 
behaviours of the dependence of the associated values as a function of time, for 
an arbitrary period of 10 years. Ideally, the gain in knowledge from the ongoing 
studies will lead to diminishing risks of product failure and a consequent rise in 
the associated and expected economical values. However, in a real situation, 
problems encountered during research may render exploitation of the natural 
resources  impractical.  Therefore,  the  inverse picture,  in  which  the  value 
decreases over time, may also occur (Fig. 2).
The development  of  advanced  science-based products  is  directly  correlated 
with  the intensive utilisation of  knowledge and high technological  standards. 
This  indicates  that  the  utilisation  of  genomics  and  synthetic  biology 
technologies in its full sense constitutes a viable option and a useful imperative 
tool  for  directing  the  sustainable  use and development  of  high  value-added 
products.  From  the  genome  to  the  creation  of  novel  biological  systems, 
metabolic pathways and molecules enginnering12,13,14 , implies the collection of a 
few organisms (or parts of them) as a source of genetic raw material that allows 
prospecting,  characterisation,  gene  expression,  new  pathways  and  genes 
arrangements  and  the  necessary  proof-of-concept  studies  (research  to 
demonstrate  the  functional  efficacy  of  a  trait  or  technology  in  the  target 
organism, to reduce the risk of product failure) aiming in a broad sense the 
improvement of human health and a sustainable use of biodiversity.Genomics 
and synthetic biology have opened the door for another breakthrough in science 
advancement.  Making  the  use  of  genomics  as  a  founded  template  on  the 
chemical  synthesis  and  assembly  using  recombinant  DNA  technology  ans 
synthetic biology allows us to manipulate and create novel metabolic pathways 
and molecules of choice. An example follows that describes one of the several 
positive  possibilities  commented  above.  Spider  silk  has  been  noted  for  its 
extraordinary  physical  and  mechanical  properties  and  has  recently  been 
recognised  as  a  protein-based  nanomaterial.  It  has  had  the  ability  to  self-
assemble into fibres consisting of antiparallel  beta-sheets for more than 450 
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million  years15.  Spider  silks  are  protein-based  biopolymers  secreted  through 
specialised  epithelial  cells  as  concentrated  soluble  precursors  of  repetitive 
building  blocks  of  primary  protein  structures.  These  biopolymers  are  highly 
flexible and exhibit extraordinary strength and toughness, comparable to high-
performance synthetic fibres such as Kevlar. Despite the high potential of spider 
silk arising from its mechanical characteristics, the impossibility of domesticating 
spiders to produce fibres in sufficient quantities has led to the development of  
alternative strategies for the production of silk proteins using synthetic biology 
recombinant DNA technology 16 
To this end, we have conducted an ongoing initiative on the functional genome 
of Brazilian spider silk glands that studies evolution at the molecular level with 
the  goal  of  developing  novel  biopolymers  through  synthetic  biology17-19.  The 
possibility  of  producing novel  biodegradable materials  with  similar  properties 
has  motivated  increased  research  on  silk  proteins  (spidroins).  Out  of  the 
genomics,different spidroin sequences produced by the major ampullate, minor 
ampullate, flagelliform and tubulliform silk glands from spiders were identified. 
The  spiders,  Nephilengys  cruentata,  Avicularia  juruensis and  Parawixia 
bistriata, were collected and prospected in the Brazilian biomes17-19. Drawing on 
genome and transcriptome data, we were able to design de novo proteins and 
produce synthetic spider-like fibres (Fig. 3). 
Currently,  different  expression  systems,  such as  bacteria20,  yeast21,  plants22, 
and  animals,23 have  been  evaluated to  define  the  most  suitable  system for 
producing synthetic spider-like proteins on a large scale at a lower cost. We 
have demonstrated the production of synthetic proteins that can form spider-like 
fibres in bacteria 16  and soybean seeds (data not shown). It is expected that in 
addition  to  the  potential  for  developing  high  value-added  and  innovative 
biomaterials, this work might also be used as a model that might fit the equation 
described in Figure 1. 
In addition to the efforts made to conserve biodiversity, an effective, evidence-
based  method  for  estimating  biodiversity value  is  necessary.  The  use  of 
Genomics  and synthetic  biology  may  constitute  an  important  tool  and  be  a 
viable option for the prospection, evaluation and manipulation of biodiversity as 
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advocated as well as be useful for developing methods for sustainable use and 
the production of novel molecules. Biotechnology may well fit into the virtuous 
circle option. Due to the urgency and strategic importance of this subject, the 
evaluation model  described here may contribute to induce the intensification 
and  establishment  of  operative  partnership  between  the  public  and  private 
sectors, along with the necessary interactions with developed countries. 
The author is grateful to Dr. Mendeli H. Vainstein for critical evaluation and Dr. 
Luciano Paulino for providing the atomic force depict. 
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Figure 1. Biotechnology and biodiversity value aggregation. This figure shows 
possible outcomes for the dependence of the associated value as a function of 
time for an arbitrary period of 10 years. The graph depicts the function 
vn(x)=100(x/10)n for varying values of n as an illustration for the various possible 
outcomes. 
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Figure 2. Biotechnology and biodiversity value aggregation. Due to problems 
during the research, the exploitation of a certain natural resource may prove 
impractical and therefore the associated value decreases with time. This figure 
shows possible outcomes for the dependence of the associated value as a 
function of time, for an arbitrary period of 10 years. The graph depicts the 
function vn(x)=100 -100(x/10)n for varying values of n as an illustration for the 
various possible outcomes.
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Figure  3. A representative atomic force microscopy image of the topographic 
surface of a synthetic spider silk-like fibre made from the synthetic recombinant 
protein17 MaSp 2 from Parawixia bistriata. 
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